| Product Code: ETC11489484 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Cannabis Pharmaceuticals Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Netherlands Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Netherlands Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance and legalization of medical cannabis in the Netherlands |
4.2.2 Growing awareness among healthcare professionals and patients about the potential benefits of cannabis pharmaceuticals |
4.2.3 Rising prevalence of chronic diseases that can be managed with cannabis-based medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for cannabis pharmaceuticals in the Netherlands |
4.3.2 Limited availability of clinical evidence supporting the efficacy and safety of cannabis-based treatments |
4.3.3 Stigma and misconceptions surrounding the use of cannabis for medical purposes |
5 Netherlands Cannabis Pharmaceuticals Market Trends |
6 Netherlands Cannabis Pharmaceuticals Market, By Types |
6.1 Netherlands Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Netherlands Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Netherlands Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Netherlands Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Netherlands Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Netherlands Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Netherlands Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Netherlands Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Netherlands Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Netherlands Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis pharmaceuticals in the Netherlands |
8.2 Patient satisfaction and reported outcomes from using cannabis-based medications |
8.3 Healthcare professional adoption rates of prescribing cannabis pharmaceuticals |
8.4 Investment and funding trends in the cannabis pharmaceuticals sector in the Netherlands |
8.5 Regulatory approvals and changes in policies related to medical cannabis in the Netherlands |
9 Netherlands Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Netherlands Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Netherlands Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Netherlands Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Netherlands Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Netherlands Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here